DE2522081C2 - - Google Patents

Info

Publication number
DE2522081C2
DE2522081C2 DE2522081A DE2522081A DE2522081C2 DE 2522081 C2 DE2522081 C2 DE 2522081C2 DE 2522081 A DE2522081 A DE 2522081A DE 2522081 A DE2522081 A DE 2522081A DE 2522081 C2 DE2522081 C2 DE 2522081C2
Authority
DE
Germany
Prior art keywords
phosphonomycin
combination
dose
mixing ratio
dosage
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
DE2522081A
Other languages
German (de)
English (en)
Other versions
DE2522081A1 (de
Inventor
Rita Dr.Phil. Hoffmann
Joseph Dr.Rer.Nat. Veser
Wolfgang Dr.Med. 6800 Mannheim De Voemel
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Roche Diagnostics GmbH
Original Assignee
Boehringer Mannheim GmbH
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Boehringer Mannheim GmbH filed Critical Boehringer Mannheim GmbH
Priority to DE19752522081 priority Critical patent/DE2522081A1/de
Priority to BE166980A priority patent/BE841775A/xx
Priority to FR7614462A priority patent/FR2311551A1/fr
Priority to GB19800/76A priority patent/GB1530017A/en
Priority to IE1031/76A priority patent/IE43373B1/en
Priority to CA252,625A priority patent/CA1068603A/en
Priority to SE7605551A priority patent/SE7605551L/xx
Publication of DE2522081A1 publication Critical patent/DE2522081A1/de
Application granted granted Critical
Publication of DE2522081C2 publication Critical patent/DE2522081C2/de
Granted legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/66—Phosphorus compounds
    • A61K31/665—Phosphorus compounds having oxygen as a ring hetero atom, e.g. fosfomycin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
    • A61K38/12—Cyclic peptides, e.g. bacitracins; Polymyxins; Gramicidins S, C; Tyrocidins A, B or C
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
    • A61K38/14—Peptides containing saccharide radicals; Derivatives thereof, e.g. bleomycin, phleomycin, muramylpeptides or vancomycin

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Epidemiology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical & Material Sciences (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Immunology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Cephalosporin Compounds (AREA)
DE19752522081 1975-05-17 1975-05-17 Antibiotisch wirksames praeparat Granted DE2522081A1 (de)

Priority Applications (7)

Application Number Priority Date Filing Date Title
DE19752522081 DE2522081A1 (de) 1975-05-17 1975-05-17 Antibiotisch wirksames praeparat
BE166980A BE841775A (fr) 1975-05-17 1976-05-13 Preparation antibiotique
FR7614462A FR2311551A1 (fr) 1975-05-17 1976-05-13 Preparation antibiotique
GB19800/76A GB1530017A (en) 1975-05-17 1976-05-13 Antibiotically active preparation
IE1031/76A IE43373B1 (en) 1975-05-17 1976-05-14 Antibiotically active preparation
CA252,625A CA1068603A (en) 1975-05-17 1976-05-14 Preparations comprising phosphonomycin and another antibiotic
SE7605551A SE7605551L (sv) 1975-05-17 1976-05-14 Antibiotiskt verksamt preparat

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE19752522081 DE2522081A1 (de) 1975-05-17 1975-05-17 Antibiotisch wirksames praeparat

Publications (2)

Publication Number Publication Date
DE2522081A1 DE2522081A1 (de) 1976-11-25
DE2522081C2 true DE2522081C2 (xx) 1987-07-30

Family

ID=5946844

Family Applications (1)

Application Number Title Priority Date Filing Date
DE19752522081 Granted DE2522081A1 (de) 1975-05-17 1975-05-17 Antibiotisch wirksames praeparat

Country Status (7)

Country Link
BE (1) BE841775A (xx)
CA (1) CA1068603A (xx)
DE (1) DE2522081A1 (xx)
FR (1) FR2311551A1 (xx)
GB (1) GB1530017A (xx)
IE (1) IE43373B1 (xx)
SE (1) SE7605551L (xx)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP2018864A1 (en) 2007-07-23 2009-01-28 Biomet Deutschland GmbH Pharmaceutical composition, substrate comprising a pharmaceutical composition, and use of a pharmaceutical composition
DE102008046610A1 (de) * 2008-09-09 2010-03-11 Biomet Deutschland Gmbh Verwendung einer pharmazeutischen Zusammensetzung zur lokalen Infektionstherapie sowie Medizinprodukt

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NL6814976A (xx) * 1968-05-15 1969-11-18
DE1924205B2 (de) * 1969-05-12 1973-01-04 Rilco Maschinenfabrik Gmbh & Co Kg, 7407 Dusslingen Druckmittelbetriebene Vorrichtung zur Erzeugung einer hin- und hergehenden Bewegung
US3678163A (en) * 1969-06-02 1972-07-18 Merck & Co Inc Stabilized aqueous suspension of calcium (-) (cis-1,2-epoxypropyl)-phosphonate
FR2100969A2 (en) * 1970-07-30 1972-03-24 Merck & Co Inc Antibiotic compns - contng (-) (cis-1,2-epoxypropyl) phosphonic acid

Also Published As

Publication number Publication date
SE7605551L (sv) 1976-11-18
BE841775A (fr) 1976-09-01
CA1068603A (en) 1979-12-25
DE2522081A1 (de) 1976-11-25
FR2311551A1 (fr) 1976-12-17
IE43373L (en) 1976-11-17
GB1530017A (en) 1978-10-25
IE43373B1 (en) 1981-02-11
FR2311551B1 (xx) 1978-11-17

Similar Documents

Publication Publication Date Title
DE2250993C2 (de) Antibakterielles Mittel
EP0240829A2 (de) Cancerostatisches Mittel
EP0330826A2 (de) Verwendung von Pyridin-2-ethern beziehungsweise Pyridin-2-thioethern mit einem stickstoffhaltigen cycloaliphatischen Ring als antidepressiv wirkende Arzneimittel
DE2522081C2 (xx)
EP0398165A1 (de) Kombinationspräparate enthaltend Rifampicin und Thioacetazon sowie gegebenenfalls Isonicotinsäurehydrazid oder Ethambutol als aktive Wirkstoffe
DE3324964C2 (xx)
DE2525064C2 (de) Arzneimittel mit Antiparkinson-Wirkung
EP1001756B1 (de) Synergistisch wirkende zusammensetzungen zur selektiven bekämpfung von tumorgewebe
DE3852717T2 (de) Zusammensetzung für die Prophylaxe von Pneumocystis-carinii-Pneumonie.
DE2521922A1 (de) Pharmazeutisches mittel
DE2451933C2 (xx)
DE3785953T2 (de) Bakterientötende Gemische.
DE2461570C3 (de) Arzneimittel für die Behandlung bakterieller Infektionen der Augen und/oder der Ohren und Verfahren zu ihrer Herstellung
DE2833014A1 (de) Antibiotisch wirksames mittel
DE2445679A1 (de) Neue immunitaets-stimulierende medikamente
EP0672411B1 (de) Verwendung von 2-Methylamino-2-phenylcyclohexanon zur Behandlung von Infektionen und zur Immunmodulation
DE2314387C3 (de) Arzneimittel zur Behandlung bösartiger Neubildungen
DE2633943A1 (de) Oral oder parenteral zu verabreichende loesung eines oxazepins
DE2721034C2 (xx)
DE2150921C2 (de) Chemotherapeutisch wirksame, zwei Wirkstoffe enthaltende Präparate
DE3147959A1 (de) Pharmazeutische zusammensetzung, die 1- 2-(3'-caroxypropionyl)oxyethyl -2-methyl-5-nitroimidazol als therapeutischen wirkstoff gegen erkrankungen enthaelt, die von anaeroben bakterien verursacht sind
DE2259624C3 (de) Antibakterielles Arzneimittel
DE3934855A1 (de) Antibakterielles synergistisches praeparat
DE2037719A1 (de) Nitrofurantoin Zusammensetzungen mit verringerten Nebenwirkungen
DE2340632A1 (de) Arzneipraeparate mit wirkung auf neoplasmen

Legal Events

Date Code Title Description
8110 Request for examination paragraph 44
D2 Grant after examination
8364 No opposition during term of opposition